Patent application number | Description | Published |
20120177752 | NUTRITIONAL COMPOSITIONS INCLUDING BETA-HYDROXY-BETA-METHYLBUTYRATE - The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5 ω-3), FOS, carnitine and mixtures thereof. HMB may be added to food products comprising a source of amino-nitrogen enriched with large neutral amino acids such as leucine, isoleucine, valine, tyrosine, threonine and phenylalanine and substantially lacking in free amino acids. | 07-12-2012 |
20120189714 | COMPOSITIONS INCLUDING BETA-HYDROXY-BETA-METHYLBUTYRATE - The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5 ω-3), FOS, carnitine and mixtures thereof. HMB may be added to food products comprising a source of amino-nitrogen enriched with large neutral amino acids such as leucine, isoleucine, valine, tyrosine, threonine and phenylalanine and substantially lacking in free amino acids. | 07-26-2012 |
20120189715 | COMPOSITIONS INCLUDING BETA-HYDROXY-BETA-METHYLBUTYRATE AND USES THEREOF - The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5 ω-3), FOS, carnitine and mixtures thereof. HMB may be added to food products comprising a source of amino-nitrogen enriched with large neutral amino acids such as leucine, isoleucine, valine, tyrosine, threonine and phenylalanine and substantially lacking in free amino acids. | 07-26-2012 |
20120189716 | METHOD OF USING BETA-HYDROXY-BETA-METHYLBUTYRATE FOR TREATING DISEASE-ASSOCIATED WASTING - The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5 ω-3), FOS, carnitine and mixtures thereof. HMB may be added to food products comprising a source of amino-nitrogen enriched with large neutral amino acids such as leucine, isoleucine, valine, tyrosine, threonine and phenylalanine and substantially lacking in free amino acids. | 07-26-2012 |
20120189717 | METHOD OF USING BETA-HYDROXY-BETA-METHYLBUTYRATE AND FATTY ACIDS FOR TREATING DISEASE-ASSOCIATED WASTING - The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5 ω-3), FOS, carnitine and mixtures thereof. HMB may be added to food products comprising a source of amino-nitrogen enriched with large neutral amino acids such as leucine, isoleucine, valine, tyrosine, threonine and phenylalanine and subtantially lacking in free amino acids. | 07-26-2012 |
20120196829 | METHOD OF USING BETA-HYDROXY-BETA-METHYLBUTYRATE FOR THE PREVENTION AND TREATMENT OF DISEASE CONDITIONS - The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5 ω-3), FOS, carnitine and mixtures thereof. HMB may be added to food products comprising a source of amino-nitrogen enriched with large neutral amino acids such as leucine, isoleucine, valine, tyrosine, threonine and phenylalanine and substantially lacking in free amino acids. | 08-02-2012 |
20130011498 | METHOD OF USING BETA-HYDROXY-BETA-METHYLBUTYRATE FOR REDUCING TUMOR GROWTH RATE - The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5 ω-3), FOS, carnitine and mixtures thereof. HMB may be added to food products comprising a source of amino-nitrogen enriched with large neutral amino acids such as leucine, isoleucine, valine, tyrosine, threonine and phenylalanine and subtantially lacking in free amino acids. | 01-10-2013 |
20150119339 | USE OF HMB TO IMPROVE HEALTH OUTCOMES FOR HOSPITALIZED PATIENTS - A method of care is described that includes administering an effective amount of β-hydroxy-β-methylbutyrate (HMB) to an adult or elderly patient to decrease the risk of an adverse health event during or subsequent to hospitalization of the patient. | 04-30-2015 |
20150133548 | COMBINATION OF BETA-HYDROXY-BETA-METHYLBUTYRATE, ARGININE AND GLUTAMINE FOR USE IN TREATING DIABETIC ULCERS - Disclosed is the combination of beta-hydroxy-beta-methylbutryate, arginine, and glutamine for use in a method of treating a diabetic ulcer in a diabetic individual having at least one of: (a) a serum albumin level of less than or equal to 4.0 g/dL, and/or (b) an Ankle-Brachial Index of less than 1.0. 9. Also disclosed is the use of the combination of beta-hydroxy-beta-methylbutryate, arginine, and glutamine for the manufacture of a medicament for use in the treatment of a diabetic ulcer in a diabetic individual having at least one of: (a) a serum albumin level of less than or equal to 4.0 g/dL, and/or (b) an Ankle-Brachial Index of less than 1.0. In certain embodiments, the combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine are orally administered via a nutritional composition. | 05-14-2015 |
Patent application number | Description | Published |
20080221043 | DENDRITIC MOLECULAR INTRACELLULAR TRANSPORTERS AND METHODS OF MAKING AND USING SAME - In accordance with the purpose(s) of the invention, as embodied and broadly described herein, the invention, in one aspect, relates to compounds comprising the structure: | 09-11-2008 |
20120277181 | LACTULOSE FOR BOWEL EVACUATION - A method of treating an adult patient in need of bowel evacuation via the administration of one or more doses of a bowel evacuant consisting of a total of from about 180 g to about 220 g of lactulose in a dosing regimen suitable to achieve bowel evacuation prior to a diagnostic, therapeutic or surgical procedure is disclosed. | 11-01-2012 |
20150315174 | Dendritic Molecular Intracellular Transporters and Methods of Making and Using Same - In accordance with the purpose(s) of the invention, as embodied and broadly described herein, the invention, in one aspect, relates to compounds comprising the structure: | 11-05-2015 |
20150328190 | Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban - The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof. | 11-19-2015 |
Patent application number | Description | Published |
20090159106 | MOBILITY DEVICES WITH INTERCHANGEABLE FEATURES - A mobility aid having interchangeable features is disclosed. A plurality of handles, shafts, and/or tips are provided of different shapes, sizes, and materials so that different users can select different features based on preference or changing support needs. Each handle and each tip is connectable to each of the provided shafts so that a user may switch out handles or tips as desired. Also disclosed is a shaft for a mobility aid having an upper portion and a lower portion with a telescoping relationship and a locking device, such as a rocking or rocker switch, interposed therebetween. The locking device allows the mobility aid to be locked into a fully expanded position, released for a semi-collapsed position, or released into a fully collapsed position. | 06-25-2009 |
20100154849 | HANDLES FOR MOBILITY DEVICES - A mobility aid, such as a cane, trek pole, or walking stick is disclosed in which the handle has an advantageous angular geometry. Also disclosed is a soft grip surface, such as a gel pad, for the handle of a mobility aid. The soft grip surface may be integral with the handle of the mobility aid or may be sold as a separate part for retrofitting existing mobility aids. The mobility aid may be provided with a variety of individualized handles for accommodating a users' desire for specialized comfort and personal stability needs. | 06-24-2010 |
20100154850 | COVERTIBLE TREK POLE - A mobility aid in the form of a trek pole is disclosed. The trek pole has a lower portion adapted to be maintained in a generally upright position when in use, an upper handle portion, and a joint between the lower portion and the upper handle portion. The joint enables the upper handle portion to be moved between an upright position typical of a trek pole, in which the upper handle portion extends upwardly from an upper end of the lower portion, to a horizontal position which provides the advantages of a cane, in which the upper handle portion extends outwardly from an upper end of the lower portion. | 06-24-2010 |
Patent application number | Description | Published |
20160083078 | DEVICE FOR PREVENTING ROTATIONAL MOVEMENT OF FAILED SELECTOR LEVER - A selector lever with two detent plates and corresponding detent pins that travel along a shaft includes a float that moves with each of the detent pins. When a detent pin fails, a float pin remains engaged with a catch, thereby preventing rotational movement of the shaft. | 03-24-2016 |
20160083079 | SELECTOR LEVER WITH INDEPENDENT SLIDES - A selector lever with redundant detent pins and detent plates and a method for using the selector lever to test for a failure of one or more detent pins. The selector lever includes at least two slides for independently moving the detent pins within the detent plates. The independent slides allow one detent pin to remain engaged. With only one detent pin engaged, the operator may test the ability to move the shaft and conclude whether or not the detent pin has failed. | 03-24-2016 |
20160085258 | SELECTOR LEVER WITH FAILURE INDICATION FEATURES - A selector lever with redundant detent pins and detent plates and a method for using the selector lever to test for a failure of one or more detent pins. The detent plates include a plurality of slots connected by a channel that corresponds to a disengaged position, enabling the detent pin to be moved from one slot to another. The selector lever includes one or more obstructing features in the channels of the detent plates. The selector lever further includes indicators for comparing the location of the shaft with the location of the obstructing features while the slide is in the disengaged position. | 03-24-2016 |
20160085259 | VISUAL FAILURE INDICATION FOR SELECTOR LEVER - A selector lever that comprises a shaft rotatably attached to a pivot and arranged between two detent plates, each of the detent plates having a plurality of slots arranged for receiving a detent pin located on the shaft. Each of the plurality of slots on each of the two detent plates is defined by a radial depth. One or more of the plurality of slots is a failure detection slot having an extended radial depth. When one of the detent pins has failed, the opposing detent pin is allowed to travel into the extended radial depth when placed in the failure detection slot. This action reveals a failure indicator, providing a visual indication that one of the detent pins has failed. | 03-24-2016 |
Patent application number | Description | Published |
20090277447 | SYSTEM, METHOD, AND DEVICE TO INCREASE CIRCULATION DURING CPR WITHOUT REQUIRING POSITIVE PRESSURE VENTILATION - In one embodiment, the invention provides a method for performing cardiopulmonary resuscitation which comprises: 1) interfacing an airway system with a patient's airway, wherein the airway system includes at least a first lumen and a second lumen; 2) repeatedly performing CPR chest compressions on the patient; and simultaneously with the CPR chest compressions; 3) applying a continuous vacuum to the first lumen for a period of time ranging from 10 seconds to the end of the CPR chest compressions; and 4) injecting an effective volume of oxygen gas into the person's lungs at high velocity through the second lumen. | 11-12-2009 |
20100319691 | VACUUM AND POSITIVE PRESSURE VENTILATION SYSTEMS AND METHODS FOR INTRATHORACIC PRESSURE REGULATION - Medical techniques include systems and methods for administering a positive pressure ventilation, a positive end expiratory pressure, and a vacuum to a person. Approaches also include treating a person with an intrathoracic pressure regulator so as to modulate or upregulate the autonomic system of the person, and treating a person with a combination of an intrathoracic pressure regulation treatment and an intra-aortic balloon pump treatment. | 12-23-2010 |
20110201979 | GUIDED ACTIVE COMPRESSION DECOMPRESSION CARDIOPULMONARY RESUSCITATION SYSTEMS AND METHODS - Systems and methods for applying guided active compression decompression cardiopulmonary resuscitation are provided. Exemplary systems include a load cell, a handle, an adhesive pad. The handle and the adhesive pad are configured for magnetic coupling. | 08-18-2011 |
20110303219 | GAS BLENDER WITH AUXILIARY MIXED GAS OUTLET - A gas blender with auxiliary mixed gas outlet for mixing a primary gas, generally air, and a secondary gas, generally oxygen, to obtain a mixed gas having several controlled characteristics. The gas blender may be incorporated into a Continuous Positive Airway Pressure (CPAP) device. The gas blender controls the mixing to produce the mixed gas having a predetermined mixture setpoint, generally an oxygen percentage, and a predetermined control setpoint, generally a pressure setpoint or flow rate setpoint. The gas blender provides an auxiliary mixed gas source for use by an auxiliary piece of equipment such as a nebulizer or resuscitation bag. The gas blender includes a primary gas inlet passageway, a secondary gas inlet passageway, a gas mixing apparatus, a mixed gas distribution passageway with an auxiliary mixed gas outlet, a gas sensor, a delivery sensor, a mixed gas delivery control valve, a mixed gas controlled passageway, and a controller. | 12-15-2011 |
20120029321 | AIRWAY ADJUNCT RESUSCITATION SYSTEMS AND METHODS - Embodiments of the present invention encompass systems and methods for administering intrathoracic pressure and cooling treatments to patients suffering from or at risk of developing heart failure, cardiac arrest, sepsis, shock, acute respiratory distress syndrome, polytrauma, head disease, elevated hepatic or portal vein pressures, bleeding during abdominal, head and neck surgery, or insufficient circulation during open heart surgery. | 02-02-2012 |
20120330200 | ENHANCED GUIDED ACTIVE COMPRESSION DECOMPRESSION CARDIOPULMONARY RESUSCITATION SYSTEMS AND METHODS - Systems and methods for applying enhanced guided active compression decompression cardiopulmonary resuscitation are provided. Exemplary systems include a load cell, a handle, an adhesive pad. The handle and the adhesive pad are configured for magnetic coupling. | 12-27-2012 |
20150202403 | VACUUM AND POSITIVE PRESSURE VENTILATION SYSTEMS AND METHODS FOR INTRATHORACIC PRESSURE REGULATION - Medical techniques include systems and methods for administering a positive pressure ventilation, a positive end expiratory pressure, and a vacuum to a person. Approaches also include treating a person with an intrathoracic pressure regulator so as to modulate or upregulate the autonomic system of the person, and treating a person with a combination of an intrathoracic pressure regulation treatment and an intra-aortic balloon pump treatment. | 07-23-2015 |
20160114113 | Systems and Methods for Therapeutic Intrathoracic Pressure Regulation - Embodiments of the present invention provide systems and methods for delivering respiratory treatment to a patient. For example, a treatment system may include a mechanism for delivering a positive pressure breath to a patient, and one or more limb flow control assemblies which modulate gas flow to and from the patient. Exemplary treatment techniques are embodied in anesthesia machines, mechanical ventilators, and manual ventilators. | 04-28-2016 |
Patent application number | Description | Published |
20090312338 | Novel Tricyclic Compounds - The invention provides a compound of Formula (I) | 12-17-2009 |
20100291088 | IL-18 BINDING PROTEINS - The present invention encompasses IL-18 binding proteins, particularly antibodies that bind human interleukin-18 (hIL-18). Specifically, the invention relates to antibodies that are entirely human antibodies. Preferred antibodies have high affinity for hIL-18 and/or that neutralize hIL-18 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Method of making and method of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting hIL-18 and for inhibiting hIL-18 activity, e.g., in a human subject suffering from a disorder in which hIL-18 activity is detrimental. | 11-18-2010 |
20110190489 | Novel Tricyclic Compounds - The invention provides a compound of Formula (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih), (Ii), (Ij), (Ik), or (Il) as defined herein, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions. | 08-04-2011 |
20110311474 | Novel Tricyclic Compounds - The invention provides compounds of Formula (I) and Formula (II) | 12-22-2011 |
20130216497 | NOVEL TRICYCLIC COMPOUNDS - The invention provides compounds of Formula (I) and Formula (II) | 08-22-2013 |
20140088296 | IL-18 BINDING PROTEINS - The present invention encompasses IL-18 binding proteins, particularly antibodies that bind human interleukin-18 (hIL-18). Specifically, the invention relates to antibodies that are entirely human antibodies. Preferred antibodies have high affinity for hIL-18 and/or that neutralize hIL-18 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Method of making and method of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting hIL-18 and for inhibiting hIL-1 activity, e.g., in a human subject suffering from a disorder in which hIL-18 activity is detrimental. | 03-27-2014 |
20140205613 | ANTI-TNF AND ANTI-IL 17 COMBINATION THERAPY BIOMARKERS FOR INFLAMMATORY DISEASE - The invention provides methods for predicting the efficacy of anti-TNF and anti-IL17 combination therapies in the treatment of a subject suffering from inflammatory disease by determining the level CXCL1 and/or CXCL5 markers in a sample derived from the subject. | 07-24-2014 |
20140349970 | NOVEL TRICYCLIC COMPOUNDS - The invention provides a compound of Formula (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih), (Ii), (Ij), (Ik), or (Il) as defined herein, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions. | 11-27-2014 |
20150118229 | JAK1 SELECTIVE INHIBITOR AND USES THEREOF - The invention relates to the use of a JAK1 kinase-selective inhibitor that has minimal inhibitory activity towards Jak2 kinase for treating a disease, such as an inflammatory disease (e.g., moderate to severe Rheumatoid Arthritis) and/or bone loss, either alone or in combination with a DMARD (disease modifying anti-rheumatic drug), such as methotrexate. The invention also provides pharmaceutical composition, dosage formulation, administration route, and dosage schedule thereof. | 04-30-2015 |
20150210708 | NOVEL TRICYCLIC COMPOUNDS - The invention provides a compound of Formula (I) | 07-30-2015 |
20160000936 | BIOMARKERS FOR INFLAMMATORY DISEASE AND METHODS OF USING SAME - The invention provides methods for predicting the efficacy of anti-TNF and anti-IL-17 combination therapies in the treatment of a subject suffering from inflammatory disease by determining the level LIF, CXCL1, CXCL2, CXCL4, CXCL5, CXCL8, CXCL9, CXCL10, CCL2, CCL23, IL-1β, IL-1Ra, TNF, IL-6, IL-10, IL-17A, IL-17F, IL-21, IL-22, IFNγ, CXCR1, CXCR4, CXCR5, GM-CSF, GM-CSFR, G-CSF, G-CSFR protein or nucleic acid, or a homolog, portion or derivative thereof markers in a sample derived from the subject. | 01-07-2016 |
Patent application number | Description | Published |
20110103002 | Modular Universal Parts and Personality Parts of a Docketing System - The disclosed docking systems for an electronic device may provide any accessory function and may include more than one connector such as a battery charger connector, a USB hub, a memory card hub, an audio boom box connector, and the like. A modular universal part is configured with at least a one connector that is configured to interface with an electronic device connector. A personality part, specific to the electronic device, is configured to receive both the electronic device and the modular universal part so that the modular universal part connector is capable of interfacing with the electronic device connector. In this way, the personality part can align the electronic device connectors with any number of modular universal part connectors. In this way, an accessory part including a modular universal part could be reuseable with different electronic devices since the personality part is specific to the electronic device. | 05-05-2011 |
20120153016 | Method and Device for Recognition of Docking Stations - A method for controlling an electronic device for use with a docking station is disclosed. The method includes detecting a coupling of the electronic device with the docking station, obtaining an image of an identifier associated with the docking station in response to detecting the coupling, and performing a predefined operation by the electronic device based on the image of the identifier in response to obtaining the image. | 06-21-2012 |
20130168445 | Method and Device for Recognition of Docking Stations - A method for controlling an electronic device for use with a docking station is disclosed. The method includes detecting a coupling of the electronic device with the docking station, obtaining an image of an identifier associated with the docking station in response to detecting the coupling, and performing a predefined operation by the electronic device based on the image of the identifier in response to obtaining the image. | 07-04-2013 |
Patent application number | Description | Published |
20090288402 | Emission Treatment Catalysts, Systems and Methods - Zoned diesel oxidation catalysts containing a higher precious metal loading in the inlet zone that the outlet zone and an equal or shorter length inlet zone are described. Emission treatment systems and methods of remediating nitrogen oxides (NOx), particulate matter, and gaseous hydrocarbons using zoned diesel oxidation catalysts are also described. | 11-26-2009 |
20100180580 | Emissions Treatment Systems and Methods With Catalyzed SCR Filter and Downstream SCR Catalyst - Emissions treatment systems and methods for treating an engine exhaust gas stream containing NO | 07-22-2010 |
20100269491 | PARTIAL FILTER SUBSTRATES CONTAINING SCR CATALYSTS AND METHODS AND EMISSIONS TREATMENT SYSTEMS - Catalytic articles, methods and emissions treatment systems for treating an engine exhaust gas stream containing NO | 10-28-2010 |
20110271664 | Integrated SCR and AMOX Catalyst Systems - Catalysts and catalytic articles for treating exhaust gas streams are described. In one or more embodiments, a catalyst system includes a first zone to abate nitrogen oxides by selective catalytic reduction, a second zone to oxidize ammonia and a third zone to oxidize carbon monoxide and hydrocarbons. Methods for treating the exhaust gas stream are also provided. Methods of making and using such catalysts and catalytic articles are also described. | 11-10-2011 |
20120258254 | Methods For Providing High-Surface Area Coatings To Mitigate Hydrocarbon Deposits On Engine And Powertrain Components - Provided are methods related to preventing hydrocarbon residue buildup in engine, exhaust-gas-system or powertrain components. Prevention is achieved by applying coating of a mixed metal oxide via a suspension plasma spray. | 10-11-2012 |
20120258266 | Coatings For Engine And Powertrain Components To Prevent Buildup Of Deposits - Provided are methods and components related to preventing hydrocarbon residue buildup in engine components. Prevention is achieved using a coating of a mixed metal oxide. The mixed metal oxide comprises a mixture of at least two of Gd, Al, Ti, Ce, Pr, La, Y, Nd, and Mn. The coating can also contain amounts of precious metals, eg. Pt, Pd, Rh and/or Au. | 10-11-2012 |
20140271429 | Zoned Catalyst For Diesel Applications - An oxidation catalyst composite, methods, and systems for the treatment of exhaust gas emissions from a diesel engine are described. More particularly, an oxidation catalyst composite including a zoned diesel oxidation catalyst with a first washcoat zone with a Pt/Pd ratio that is less than 3:1 and a PGM loading at least twice that of a second washcoat zone. | 09-18-2014 |
20150298098 | Zoned Catalyst Composites - Provided herein are zoned catalysts that utilize components efficiently in that relatively short zones are provided to achieve specific functionalities to convert and/or trap one or more components in the exhaust stream. Highly controlled zoned are formed from one end of a monolithic carrier. The zones have a flat profile such that the zoned catalytic material within each passage of the substrate is at a substantially uniform distance from one end of the carrier. Methods of making and using the same are also provided. | 10-22-2015 |
Patent application number | Description | Published |
20080217800 | METHOD FOR STABILIZING LENS MOLD ASSEMBLY - The invention provides for partially curing a flash ring during mold assembly to make the ring sufficiently tacky so that the back mold half will remain adhered to the mold assembly during the subsequent cure processing. | 09-11-2008 |
20110017243 | PORTIONED PACKAGES FOR MAINTENANCE SOLUTIONS AND OPHTHALMIC LENSES - A package for a portion of maintenance solution and an ophthalmic lens and methods of using the same. | 01-27-2011 |
20110092925 | LIQUID DISPENSING WITH BLINK DETECTION - This invention discloses methods and apparatus for providing a variable optic insert into an ophthalmic lens. An energy source is capable of powering the variable optic insert included within the ophthalmic lens. In some embodiments, an ophthalmic lens is cast molded from a silicone hydrogel. | 04-21-2011 |
20110106025 | OPHTHALMIC FLUID PUMP - This invention discloses apparatus and methods of providing a pump for dispensing a liquid into the eye and in some embodiments, a pump coupled to a blink detecting mechanism to time administration of a liquid into the eye. | 05-05-2011 |
20110284764 | OPHTHALMIC LENS DISINFECTING BASE - The present invention provides for a disinfecting radiation base for working in conjunction with a storage case for an ophthalmic lens. The disinfecting radiation base provides disinfecting radiation for disinfecting an ophthalmic lens. The disinfecting radiation base may also include a processor and digital memory for automated functions associated with the base. | 11-24-2011 |
20110284772 | LIGHT EMITTING DIODE DISINFECTION BASE FOR OPHTHALMIC LENSES - The present invention provides for a disinfecting radiation base for working in conjunction with a storage case for an ophthalmic lens. The disinfecting radiation base provides disinfecting radiation for disinfecting an ophthalmic lens. The disinfecting radiation base may also include a processor and digital memory for automated functions associated with the base. | 11-24-2011 |
20110284773 | GERMICIDAL BULB DISINFECTION BASE FOR OPHTHALMIC LENSES - The present invention provides for a disinfecting radiation base with a germicidal bulb for providing disinfecting radiation to a storage case for an ophthalmic lens, such as a contact lens. The disinfecting radiation base provides disinfecting radiation for disinfecting a contact lens. The disinfecting radiation base may also include a processor and digital memory for automated functions associated with the base. | 11-24-2011 |
20120273451 | ANGLED PIERCING FLIPTOP CLOSURE - The invention closures that opens sealed containers and close such containers thereafter and method of using the same. | 11-01-2012 |
20130085459 | METHOD AND DEVICE FOR DOSAGE AND ADMINISTRATION FEEDBACK - This invention provides for a method and an EMDU used to dispense precise quantities of liquids with an image sensor being capable of providing feedback to the user as to both, when an eye is properly aligned with the EMDU, and to detect and track the quantity of the dose administered on to the eye. | 04-04-2013 |
20130085460 | METHOD AND APPARATUS FOR LIQUID DISPENSING - This invention provides for a method and a device for dispensing precise quantities of a predetermined volume of medicaments or other liquids onto the eye, via one or more discrete drop(s) generated by the device in a practical and innoxious way to users. | 04-04-2013 |
20130172831 | LIQUID DISPENSING RESERVOIR - This invention provides for a device and methods of dispensing a precise predetermined volume of liquid of discrete drops, vapor, or mist while preventing contamination due to Pull Back and ensuring precision dispensing. | 07-04-2013 |
20150250915 | CONTACT LENS STORAGE CASE SURFACE DISINFECTION - The present invention provides for a disinfecting radiation base for working in conjunction with a storage case for an ophthalmic lens. The disinfecting radiation base provides disinfecting radiation for disinfecting a surface of the storage case. The disinfecting radiation base may also include a processor and digital memory for automated functions associated with the base. | 09-10-2015 |
20160061689 | IN-LINE INSPECTION OF OPHTHALMIC DEVICE WITH AUTO-ALIGNMENT SYSTEM AND INTERFEROMETER - Disclosed are in-line apparatuses, systems and methods for measuring a physical characteristic of a constant supply of an ophthalmic device, the apparatuses including: an interferometer; an automatic alignment system that positions the interferometer or ophthalmic device; and a central processing unit in communication with the automatic alignment system and receiving measurements from the interferometer. The in-line apparatus measures the desired physical dimensions of the ophthalmic device in real time. In-line systems, apparatuses and methods for measuring a physical characteristic of an ophthalmic device can include: a camera imaging an actual position of a feature of the ophthalmic device; a vibration resistant interferometer projecting a surface measurement beam having a wavelength that transmits through a beam splitter onto the ophthalmic device; and an automatic alignment system positioning the interferometer and the camera. | 03-03-2016 |
Patent application number | Description | Published |
20100124685 | INTEGRATED SOLID OXIDE FUEL CELL AND FUEL PROCESSOR - A fuel cell unit includes a plurality of angularly spaced fuel cell stacks arranged to form a ring-shaped structure about a central axis, each of the fuel cell stacks having a stacking direction extending parallel to the central axis. The fuel cell unit also includes an annular cathode feed manifold surrounding the fuel cell stacks to deliver a cathode feed flow thereto, a plurality of baffles extending parallel to the central axis, each of the baffles located between an adjacent pair of the fuel cell stacks to direct a cathode feed flow from the annular cathode feed manifold and radially inwardly through the adjacent pair, and an annular cathode exhaust manifold surrounded by the fuel cell stacks to receive a cathode exhaust flow therefrom | 05-20-2010 |
20120015258 | COMPACT AIR PREHEATER FOR SOLID OXIDE FUEL CELL SYSTEMS - The present invention provides, among other things, a method of operating a solid oxide fuel cell system including a fuel cell stack. The method can include the acts of combining an exhaust flow from an anode side of the fuel cell stack and an exhaust flow from a cathode side of the fuel cell stack, transferring heat from the combined exhaust flow to a first air flow, and combining a second air flow and the heated first air flow upstream from the fuel cell stack to control a temperature of the combined air flow entering the cathode side of the solid oxide fuel cell. | 01-19-2012 |
20130199173 | RANKINE CYCLE SYSTEM AND METHOD - A Rankine cycle system and method is described and illustrated, and in some embodiments includes an expander, a pump, a condenser, and a receiver comprising a variable fluid volume at least partially defined by a movable member, wherein the variable fluid volume defines at least a portion of the working fluid flow path between the condenser and the inlet of the pump. Also, a method of charging a Rankine cycle system with working fluid is described and illustrated, and can include applying a regulated pressure to a chamber located within a receiver, introducing the working fluid to the Rankine cycle system, the working fluid being separated from the chamber by a movable member of the receiver, monitoring displacement of the movable member, and stopping the introduction of working fluid into the Rankine cycle system when the movable member reaches a predetermined position. | 08-08-2013 |
20150377077 | ORGANIC RANKINE CYCLE WASTE HEAT RECOVERY SYSTEM - A Rankine cycle for recovering waste heat from an engine includes a Rankine cycle circuit having a pump, a heat exchanger, an expansion device, a cooling device and a bypass circuit. The bypass circuit selectively provides a flow path for working fluid to bypass the expansion device, and includes a flow control valve actuated by a working fluid pressure differential to selectively open or close the bypass flow path. The expansion device includes a drive member directly coupled to a front end accessory drive (FEAD) of the engine such that a rotational speed of the expansion device is dictated by engine speed and the expansion device is free from separate speed control. The expansion device provides torque to the FEAD via the drive member when the system is in a waste heat recovery mode thereby reducing engine load and improving fuel economy. | 12-31-2015 |
Patent application number | Description | Published |
20090088568 | VINORELBINE DERIVATIVES - The present invention relates to novel vinorelbine derivatives. Pharmaceutical compositions containing these compounds as well as processes of preparation and processes of use for treatment of various conditions are also disclosed. | 04-02-2009 |
20100286190 | CERTAIN SUBSTITUTED UREAS, AS MODULATORS OF KINASE ACTIVITY - Certain chemical entities chosen from compounds of Formula 1 and pharmaceutically acceptable salts, solvates, chelates, non-covalent complexes, and prodrugs thereof, are provided herein. Pharmaceutical compositions comprising at least one chemical entity and one or more pharmaceutically acceptable vehicles chosen from carriers, adjuvants, and excipients, are also provided herein. Methods of treating patients suffering from certain diseases and disorders responsive to angiogenic kinase modulation, which comprise administering to such patients an amount of at least one chemical entity effective to reduce signs or symptoms of the disease or disorder are disclosed. These diseases include cancer, including breast neoplasia, endometrial cancer, colon cancer, and neck squamous cell carcinoma. Methods of treatment include administering at least one chemical entity as a single active agent or administering such at least one chemical entity in combination with one or more other therapeutic agents. A method for determining the presence or absence of an angiogenic kinase in a sample comprising contacting the sample with at least one chemical entity under conditions that permit detection of activity of the angiogenic kinase, detecting a level of the activity of the angiogenic kinase, and therefrom determining the presence or absence of the angiogenic kinase in the sample. | 11-11-2010 |
Patent application number | Description | Published |
20120057035 | FORCE COMPENSATION SYSTEMS AND METHODS - A positioning system and method are disclosed. The system includes an external force sensor configured to measure a magnitude of at least one external force acting upon a movable object disposed within a camera and to generate a force signal that is indicative of the magnitude of the at least one external force. The system also includes a positioning motor configured to control a physical location of the movable object in response to a positioning signal. The system further includes a position controller configured to generate the positioning signal at a magnitude that is adjusted in response to the force signal to substantially compensate for the at least one external force in controlling the physical location of the movable object. | 03-08-2012 |
20120075482 | IMAGE BLENDING BASED ON IMAGE REFERENCE INFORMATION - A target image is obtained from a cloud database based on reference information associated with a source image that is captured by an image capture device. The target image is blended with the source image to generate a blended image. | 03-29-2012 |
20120081569 | Detection of flicker within captured imaged frames - A readout frequency of a sensor of a digital image capturing device is set based on a frequency of alternating current (AC) mains so that a readout period of the sensor of the digital image capturing device is not an integer multiple of a flicker period. The flicker period is equal to half of a period of the AC mains. A first image frame and a second image frame are captured using the sensor of the digital image capturing device. The second image frame is captured later in time than the first image frame. Whether flicker has occurred in the first and second image frames due to a periodic fluctuation of light emitted by a light source powered by the AC mains is detected by comparing a brightness of an area of the first image frame to a brightness of a corresponding area of the second image frame. | 04-05-2012 |
20120086825 | AUTOMATIC ADJUSTMENT OF CAPTURE PARAMETERS BASED ON REFERENCE DATA - Reference data associated with an image capture device is collected while the image capture device is directed toward a scene area. A capture control on the image capture device is automatically adjusted based at least in part on the reference data. | 04-12-2012 |
20120154559 | Generate Media - A device to calibrate with a 3D viewer, to couple to a display device, and to split a 3D signal to a first 2D signal and a second 2D signal and generate media to be rendered on the display device by merging the first 2D signal and the second 2D signal based on a timing between the device and the 3D viewer. | 06-21-2012 |
20120301103 | Storing a Location within Metadata of Visual Media - A device to detect location data, store a first location of the device within metadata of visual media if the location data is available, and store a second location within the metadata of the visual media if the location data is unavailable. | 11-29-2012 |
20120309407 | Mode of Operation based on Image Capture Profile - A device to detect a location of a device, identify an image capture profile associated with the location of the device, and modify a mode of operation on the device based on the image capture profile. | 12-06-2012 |
20120331384 | DETERMINING AN OPTION BASED ON A REACTION TO VISUAL MEDIA CONTENT - Implementations disclosed herein relate to determining an option based on a reaction to visual media content. In one implementation, a processor determines a user's degree of preference for visual media content and selects an option based on the determined degree of preference. The processor may provide the determined degree of preference. | 12-27-2012 |
20130027606 | LENS POSITION - Embodiments provide methods, apparatuses, and articles of manufacture for generating frames and changing lens positions based on the analysis of the frames. In one example, a controller coupled to a first camera and a second camera is to change a lens position of the first camera for a second frame based on the identification of a focal target in a frame generated by the second camera. | 01-31-2013 |
20130027775 | IMAGE STABILIZATION - Example embodiments disclosed herein relate to image stabilization. Image stabilization includes techniques used to reduce jitter associated with the motion of a camera. Image stabilization can compensate for pan and tilt (angular movement, equivalent to yaw and pitch) of a camera or other imaging device. Image stabilization can be used in still and video cameras, including those found in mobile devices such as cell phones and personal digital assistants (PDAs). | 01-31-2013 |
20130028519 | FEATURE BASED IMAGE REGISTRATION - Example embodiments disclosed herein relate to feature based image registration. Feature based image registration determines correspondence between image features such as points, lines, and contours to align or register a reference or first image and a target or second image. The examples disclosed herein may be used in mobile devices such as cell phones, personal digital assistants, personal computers, cameras, and video recorders. | 01-31-2013 |
20130094753 | FILTERING IMAGE DATA - Systems, methods, and machine-readable and executable instructions are provided for filtering image data. Filtering image data can include determining a desired depth of field of an image, determining a distance between a pixel of the image and the desired depth of field. Filtering image data can also include adjusting a contrast of the pixel in proportion to a magnitude of a weight of the pixel, wherein the weight is based on the distance. | 04-18-2013 |
20130195435 | CAMERA FLASH FILTER - Embodiments disclosed herein relate to a camera flash filter. In one embodiment, a processor determines an intensity of light to filter through areas of the flash filter based on the lighting of a scene. The processor may determine a color of light to filter though the areas of the flash filter based on the determined intensity of light to filter through the areas of the flash filter. | 08-01-2013 |
20130201368 | ALTERING FOCUS LENS MAGNIFICATION IN A VIDEO FRAME - A focus lens is moved to a position within a range of focus lens positions. A video frame is captured with the focus lens at that position. The magnification of the first video frame is altered according to a maximum magnification threshold associated with the range of focus lens positions. | 08-08-2013 |
20130208164 | BLEMISH DETECTION AND NOTIFICATION IN AN IMAGE CAPTURE DEVICE - A lens on an image capture device is illuminated with a known light source. The current light field created by illuminating the lens is measured at an image sensor on the device. In response to detecting that the current light field measurement fails to satisfy a threshold, a notification is provided on the device. | 08-15-2013 |
20130259459 | LENS POSITION BASED ON FOCUS SCORES OF OBJECTS - Embodiments herein relate to setting a lens position based on focus scores. A plurality of initial positions of a lens are determined. Each of the initial positions may correspond to a position of the lens at which one of a plurality of objects has a highest quality. A focus score may be determined at each of the initial positions for the corresponding object having the highest quality. A final position of the lens between two of the initial positions may be calculated based on the focus scores. | 10-03-2013 |
20130286249 | AUTOMATICALLY CAPTURING IMAGES THAT INCLUDE LIGHTNING - A method is disclosed for capturing one or more images that include a lightning strike using an image capturing device. The method is performed by one or more processors of the image capturing device. The one or more processors automatically capture a plurality of images during a period of time using the lens of the device. Each of the plurality of images is processed to detect a presence of lightning within each image. Each image is processed based, at least part, on two consecutive captured images. Images that have been determined to include the presence of lightning are stored in a memory resource of the image capturing device. | 10-31-2013 |
20140125835 | Visual Media on a Circular Buffer - A device to capture visual media, transiently store the visual media on a circular buffer, detect for a trigger from an environment around the device, and store the visual media on a location of a storage component separate from the circular buffer in response to detecting the trigger. | 05-08-2014 |
20140253746 | DEPTH MASK ASSISTED VIDEO STABILIZATION | 09-11-2014 |
20140340566 | IMAGING DEVICE - Example embodiments disclosed herein relate to an imaging device and method. One example of such an imaging device includes a focus imaging unit and a camera imaging unit. The camera imaging unit is separate from the focus imaging unit and is configured to record an image. The imaging device additionally includes a focusing unit coupled to the focus imaging unit and the camera imaging unit. This focusing unit is configured to adjust a focus position of the focus imaging unit and the camera imaging unit. The imaging device further includes a control unit that is configured to actuate the focusing unit to adjust the focus position of the focus imaging unit and to thereby determine an optimal focus position, and to actuate the focusing unit to adjust the focus position of the camera imaging unit based on the determined optimal focus position. | 11-20-2014 |
Patent application number | Description | Published |
20110250176 | Combinations of Hepatitis C Virus Inhibitors - The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating Hepatitis C using such combinations. | 10-13-2011 |
20120196794 | Combinations of Hepatitis C Virus Inhibitors - The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating hepatitis C using such combinations. | 08-02-2012 |
20130259832 | Combinations of Hepatitis C Virus Inhibitors - The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating Hepatitis C using such combinations. | 10-03-2013 |
20140235617 | Combinations of Hepatitis C Virus Inhibitors - The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating hepatitis C using such combinations. | 08-21-2014 |
20150335655 | Combinations of Hepatitis C Virus Inhibitors - The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating hepatitis C using such combinations. | 11-26-2015 |
Patent application number | Description | Published |
20110168311 | VARIABLE SURFACE AREA TIRE TREAD AND TIRE - Particular embodiments of the present invention include a multi-stage tire tread having a plurality of wear layers, each said layer being located at a different depth of the tire tread, the tread including one or more tread elements including a contact surface and having a first wear layer and a second wear layer, wherein the second wear layer is located below the first wear layer. The tire tread also includes a longitudinal groove extending in a longitudinal direction within the second wear layer of the tread element, wherein said longitudinal groove becomes exposed after a depth of the first wear layer has been worn. The tire tread further includes one or more lateral grooves extending from the longitudinal groove in a lateral direction within the second wear layer of the tread element. The invention also provides a mold element for forming portions of the multi-stage tread. | 07-14-2011 |
20120035756 | POST CURE TIRE SIPING FOR PREVENTING IRREGULAR WEAR - Tires in use wear in a host of ways. One negative manner in which tires, especially truck tires, may wear is in an irregular fashion. When this phenomenon happens, the tread of the tire may become unusable, forcing the user to replace the tire, which is undesirable. This patent application poses a new and useful way of preventing irregular wear involving the addition of a predetermined configuration of pipes, increasing the useful life of the tire tread. | 02-09-2012 |
20130014873 | TIRE HAVING TREAD WITH HIDDEN TREAD BLOCKS - Tires in use wear in a host of ways. One negative manner in which tires, especially truck tires, may wear is in an irregular fashion. When this phenomenon happens, the tread of the tire may become unusable, forcing the user to replace the tire, which is undesirable. This patent application poses a new and useful way of preventing irregular wear involving the use of hidden sipes or tread blocks. In some embodiments, these hidden sipes or tread blocks are found in tread blocks or ribs adjacent other tread blocks or ribs that have been determined to be susceptible to irregular wear. In other embodiments, the hidden sipes or tread blocks are formed by a sipe blade that has a connecting member to which two y-branched members are attached, and further comprising dividing members that connect between the y-branched members. | 01-17-2013 |
Patent application number | Description | Published |
20090100536 | Transgenic plants with enhanced agronomic traits - This invention provides transgenic plant cells with recombinant DNA for expression of proteins that are useful for imparting enhanced agronomic trait(s) to transgenic crop plants. This invention also provides transgenic plants and progeny seed comprising the transgenic plant cells where the plants are selected for having an enhanced trait selected from the group of traits consisting of enhanced water use efficiency, enhanced cold tolerance, increased yield, enhanced nitrogen use efficiency, enhanced seed protein and enhanced seed oil. Also disclosed are methods for manufacturing transgenic seed and plants with enhanced traits. | 04-16-2009 |
20110258734 | GENE SEQUENCES AND USES THEREOF IN PLANTS - This invention provides transgenic plant cells with recombinant DNA for expression of proteins that are useful for imparting enhanced agronomic trait(s) to transgenic crop plants. This invention also provides transgenic plants and progeny seed comprising the transgenic plant cells where the plants are selected for having an enhanced trait selected from the group of traits consisting of enhanced water use efficiency, enhanced cold tolerance, increased yield, enhanced nitrogen use efficiency, enhanced seed protein and enhanced seed oil. Also disclosed are methods for manufacturing transgenic seed and plants with enhanced traits. | 10-20-2011 |
20130074202 | GENE SEQUENCES AND USES THEREOF IN PLANTS - This invention provides transgenic plant cells with recombinant DNA for expression of proteins that are useful for imparting enhanced agronomic trait(s) to transgenic crop plants. This invention also provides transgenic plants and progeny seed comprising the transgenic plant cells where the plants are selected for having an enhanced trait selected from the group of traits consisting of enhanced water use efficiency, enhanced cold tolerance, increased yield, enhanced nitrogen use efficiency, enhanced seed protein and enhanced seed oil. Also disclosed are methods for manufacturing transgenic seed and plants with enhanced traits. | 03-21-2013 |